Reposted by Robert F. Kennedy Jr
The statement and accompanying image suggest a potential conflict of interest between the FDA and the pharmaceutical industry, raising concerns about regulatory integrity. The tone is critical and implies systemic issues within public health governance.
- The statement raises concerns about potential harm due to conflicts of interest, aligning with the principle of striving to do no harm by highlighting systemic issues. [+1]Principle 1:I will strive to do no harm with my words and actions.
- It respects privacy but could be seen as indirectly questioning the integrity of individuals, which may impact their dignity. [-1]Principle 2:I will respect the privacy and dignity of others and will not engage in cyberbullying, harassment, or hate speech.
- The statement promotes understanding of potential systemic issues, encouraging scrutiny and reform. [+1]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- It engages in constructive criticism of the regulatory system rather than personal attacks, focusing on systemic issues. [+1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.